The CMC (Chemistry, Manufacturing and Controls) Specialist will focus on supervising our outsourced process development activities and maintenance of manufacturing processes. The ideal candidate will have in-depth knowledge and/or experience in at least one of the following areas – developing various chromatography-based purification techniques, impurity clearance or mammalian cell culturing for biopharmaceuticals. The goal of Faron CMC is to work consistently and with precision to advance our development programs, and we hope to find a like-minded professional to join our team.
Key responsibilities
- Supervision of outsourced process development work (especially downstream) and maintenance of up-to-date documentation and archives
- Development, validation and maintenance of manufacturing processes suitable for GMP manufacture and desired impurity clearance
- Identifying process changes and improvements
- Designing process control strategy together with QC specialist
- Review of master and executed production records for technical and GMP compliance
- Supporting regulatory submission files as required
Ideal candidate
- BSc or MSc in relevant scientific discipline with a minimum of 1-3 years of experience in process development and manufacturing in pharmaceutical industry; preferably with biopharmaceuticals
- In-depth knowledge and experience in purification techniques based on chromatrography and their development, development of process control strategies and impurity clearance, designing experiments with sound scientific rationale and troubleshooting and understanding of protein chemistry and related regulatory requirements; principles about mammalian cell culturing, bioprocesses and bioreactors
- Experience in supervision and reporting of outsourced work
- Precise documenting skills
- Good communication skills and excellent written and verbal English skills
- Strong analytical and problem-solving skills
Finding the right person with a passionate and professional attitude to enhance our talented team is priority for us. The ability to learn on-the-go and to face new situations and challenges head-on are valued at Faron. The person we are looking for excels in project and time management with multiple priorities, and works well independently, also under pressure. To find the right person for our work community, we are open to discussing the role’s responsibilities and employment details (e.g. location of the applicant) based on the candidate’s profile. The position will report to VP, CMC at Faron.
Why Faron?
At Faron, your work is a meaningful part in our mission to transform cancer care. We value the willingness to develop processes and face new situations and challenges directly. To support this, we offer good opportunities to develop your own professional skills through a range of training courses.
With us you can be part of dynamic working environment with a culture of collaboration and open communication. Our office is located in Turku, Finland. We support a hybrid working model, but would be happy to see you in the office at least once a week.
Interested and confident you could be the person we are looking for? Please submit your application with your CV via our Career site by 25 June, 2025 at the latest. We may start going through possible candidates already during the application period.
For any further questions about the position, please contact the hiring manager VP CMC, Marita Vainio at marita.vainio@faron.com. She will also be available for phone inquiries at +358 406885547 on:
- Thursday, 12 June 15:00-16:00
- Monday 23 June 15:00-15:30
For further support with submitting your application, please contact careers@faron.com. Please note that applications sent via email cannot be processed due to privacy reasons.
Faron is a clinical stage biopharmaceutical company focused on tackling cancers via novel immunotherapies. Our mission is to bring the promise of immunotherapy to a broader population by uncovering novel ways to control and harness the power of the immune system. The Company’s lead asset is bexmarilimab, a novel anti-Clever-1 humanized antibody, with the potential to remove immunosuppression of cancers through reprogramming myeloid cell function. The company was founded in 2007 in Turku, Finland.
